Olivia Iheanacho
Psychiatric/Mental Health · Austin, TXNPI 1154851129
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 345 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,733, 7.9 times the $475 reported in 2023. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 345 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$808
- Alkermes, Inc.$655
- Corium, LLC$411
- Lundbeck LLC$401
- Harmony Biosciences LLC$373
- plus $3K from 19 others
What the payments were for
- Food & beverage$6,50097%
- Education$1673%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 71 | $1,160 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 39 | $808 |
| Alkermes, Inc. | 33 | $655 |
| Corium, LLC | 20 | $411 |
| Lundbeck LLC | 21 | $401 |
| Harmony Biosciences LLC | 9 | $373 |
| Neurocrine Biosciences, Inc. | 16 | $372 |
| Vanda Pharmaceuticals Inc. | 18 | $371 |
| AbbVie | 21 | $322 |
| Teva Pharmaceuticals USA, Inc. | 18 | $300 |
| Bausch Health US, LLC | 13 | $283 |
| E.r. Squibb & Sons, L.L.C. | 15 | $261 |
| Axsome Therapeutics, Inc. | 14 | $256 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $143 |
| Johnson & Johnson | 6 | $123 |
| Noven Therapeutics, LLC | 6 | $116 |
| Collegium Pharmaceutical, Inc. | 5 | $93 |
| Indivior Inc. | 2 | $40 |
| Ironshore Pharmaceuticals Inc. | 2 | $37 |
| Tris Pharma Inc | 2 | $36 |
| Acadia Pharmaceuticals Inc | 1 | $27 |
| Biogen | 1 | $26 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
How this compares
$6,667 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Austin
- Jaime Nelson DensonAustin$88K
- Camille WatsonAustin$34K
- Suzanne GranthamAustin$31K
- Lin CaiAustin$16K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.